Monolithic Chromatography for High-Purity RNA Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current RNA purification methods are inefficient and unsuitable for large-scale or small-scale pharmaceutical-grade RNA production, particularly in high-throughput settings, as they fail to achieve high yield, pharmaceutical-grade purity, and stability while being cost- and time-effective, and are not compatible with alkaline cleaning solutions.
Innovation Solution
A method involving the application of RNA samples in high salt concentrations to monolithic columns with hydroxyl or sulfate ligands for binding and elution, allowing for the purification, concentration, and polishing of RNA under high salt conditions without the need for polar interaction chromatography or anion exchange chromatography.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If RNA precipitation is used for purification, then high molecular weight contaminants and low molecular weight contaminants are depleted, but the process is time-consuming and requires alcohols and organic solvents that are incompatible with cGMP
Solution Approach 1:
The invention changes the fundamental parameters of the purification process by using hydrophobic interaction chromatography with monolithic columns instead of precipitation. This allows purification to proceed in aqueous buffers without organic solvents, reducing time while maintaining pharmaceutical-grade purity
Solution Approach 2:
The invention replaces the mechanical precipitation process with a chromatographic separation system using monolithic columns. This substitution eliminates the need for alcohol addition, centrifugation, and resuspension steps, significantly reducing processing time while achieving comparable or superior purity
2Manufacturing precision
If silica-based columns are used for RNA purification, then RNA can be purified, but the columns are not compatible with alkaline cleaning solutions
Solution Approach 1:
The invention uses composite monolithic column materials composed of polymer-based matrices functionalized with hydrophobic groups. These composite materials provide both the necessary RNA binding capabilities and resistance to alkaline cleaning solutions, enabling versatile column maintenance and reuse
Solution Approach 2:
The monolithic columns are designed with specific local properties - hydrophobic functional groups positioned to bind RNA while the bulk polymer matrix provides chemical resistance. This local differentiation of material properties enables both purification functionality and cleaning compatibility
3Manufacturing precision
If multiple chromatographic steps are used for purification, then high purity RNA is achieved, but the process complexity and time increase
Solution Approach 1:
The monolithic columns are designed with universal applicability for different RNA types and scales. The single column design performs multiple functions - binding, washing, and elution - that previously required multiple specialized chromatographic steps, thereby reducing process complexity while maintaining high purity
Solution Approach 2:
The invention merges multiple purification functions into a single chromatographic step using monolithic columns. The column combines binding, washing, and elution capabilities that previously required separate operations, simplifying the overall process while achieving pharmaceutical-grade purity
4Manufacturing precision
If traditional chromatography methods are used, then RNA purification is achieved, but the methods are not scalable for both small and large scale preparations
Solution Approach 1:
The monolithic column system is designed with dynamic scalability - the same column technology can be operated at different flow rates and scales. Small-scale research applications and large-scale pharmaceutical production can both use the same fundamental column design, simply adjusting operational parameters to match the required scale
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively purifies RNA by binding to hydroxyl or sulfate ligands under high salt conditions, achieving high purity and stability, and is scalable for both small and large-scale applications, compatible with alkaline cleaning solutions, and suitable for pharmaceutical-grade RNA production.
Implementation Method 1
purifying a nucleic acid by chromatography under high salt conditions, e.g. by hydrophobic interaction chromatography
Implementation Method 2
eluting the nucleic acid from the support material with an elution solution
Data Source
AI summary
The present invention relates to methods for purifying RNA by chromatography under high salt conditions, e.g. by hydrophobic interaction chromatography.